findmyKOL
Clinical trialNCT02585388TerminatedPhase 2Interventional

Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.

SponsorARCAGY/ GINECO GROUPEnrollment120Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Centre Hospitalier de L'Agglomération Montargoise

    Amilly, France

  • Ico Paul Papin

    Angers, France

  • Institut Sainte-Catherine

    Avignon, France

  • Centre Hospitalier de la Côte Basque

    Bayonne, France

  • Centre Hospitalier Fleyriat

    Bourg-en-Bresse, France

  • Chu de Brest

    Brest, France

  • Clinique Pasteur

    Brest, France

  • Centre Hospitalier Alpes Léman

    Contamine-sur-Arve, France

  • Ch de la Dracénie

    Draguignan, France

  • Centre Hospitalier Intercommunal Des Alpes Du Sud

    Gap, France

  • Chu de Grenoble

    Grenoble, France

  • Groupe Hospitalier Mutualiste de Grenoble

    Grenoble, France

  • Hôpital Privé Drôme Ardèche - Clinique Pasteur

    Guilherand-Granges, France

  • Hôpital Privé Drôme Ardèche

    Guilhérand-Granges, France

  • Chd Vendée

    La Roche-sur-Yon, France

  • Centre Hospitalier de Laon

    Laon, France

  • Ch Chartres Hôpital Louis Pasteur

    Le Coudray, France

  • Centre Hospitalier Le Mans

    Le Mans, France

  • Centre Léon Berard

    Lyon, France

  • Hôpital Privé Jean Mermoz

    Lyon, France

  • Hôpital Privé Jean Mermoz

    Lyon, France

  • Ch Layne

    Mont-de-Marsan, France

  • Ch Montélimar

    Montélimar, France

  • Centre Azuréen de Cancérologie

    Mougins, France

  • Oracle

    Nancy, France

  • Centre Catherine de Sienne

    Nantes, France

  • Chr Orléans

    Orléans, France

  • Centre Hospitalier de Pau

    Pau, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

  • Hopital Privé Des Côtes D'Armor

    Plérin, France

  • Centre Hospitalier Annecy-Genevois

    Pringy, France

  • Centre Hospitalier de la Région D'Annecy

    Pringy, France

  • Polyclinique Francheville

    Périgueux, France

  • Centre Hospitalier de Quimper

    Quimper, France

  • Institut Jean Godinot

    Reims, France

  • Institut Du Cancer Courlancy Reims

    Reims, France

  • Centre Hospitalier de Romans Sur Isère

    Romans-sur-Isère, France

  • Hôpitaux Drôme Nord - Site de Romans

    Romans-sur-Isère, France

  • Chp Saint Grégoire

    Saint-Grégoire, France

  • Ico Gauducheau

    Saint-Herblain, France

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Oct 2015
Primary completion
15 May 2017
Completion
15 May 2017
Last update posted
6 Sept 2023
Registered enrollment
120
Registry id
NCT02585388

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.